Autoimmunity as a Predisposition for Infectious Diseases


article has not abstract


Vyšlo v časopise: Autoimmunity as a Predisposition for Infectious Diseases. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001077
Kategorie: Opinion
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001077

Souhrn

article has not abstract


Zdroje

1. ShoenfeldY

1994 Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 8 1296 1301

2. KivityS

Agmon-LevinN

BlankM

ShoenfeldY

2009 Infections and autoimmunity—friends or foes? Trends Immunol 30 409 414

3. Agmon-LevinN

PazZ

IsraeliE

ShoenfeldY

2009 Vaccines and autoimmunity. Nat Rev Rheumatol 5 648 652

4. InvernizziP

GershwinME

2009 The genetics of human autoimmune disease. J Autoimmun 33 290 299

5. HewagamaA

RichardsonB

2009 The genetics and epigenetics of autoimmune diseases. J Autoimmun 33 3 11

6. ZhuJ

PaulWE

2008 CD4 T cells: fates, functions, and faults. Blood 112 1557 1569

7. BettelliE

KornT

OukkaM

KuchrooVK

2008 Induction and effector functions of T(H)17 cells. Nature 453 1051 1057

8. DubinPJ

KollsJK

2008 Th17 cytokines and mucosal immunity. Immunol Rev 226 160 171

9. AimaniandaV

HaenslerJ

Lacroix-DesmazesS

KaveriSV

BayryJ

2009 Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharmacol Sci 30 287 295

10. DinarelloCA

2003 Anti-cytokine therapeutics and infections. Vaccine 21 Suppl 2 S24 34

11. WinthropKL

ChillerT

2009 Preventing and treating biologic-associated opportunistic infections. Nat Rev Rheumatol 5 405 410

12. Marodi L, Casanova JL Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies? Nat Rev Immunol 10 299 300

13. MadariagaL

AmurrioC

MartinG

Garcia-CebrianF

BicandiJ

1998 Detection of anti-interferon-γ autoantibodies in subjects infected by Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2 62 68

14. DoffingerR

HelbertMR

Barcenas-MoralesG

YangK

DupuisS

2004 Autoantibodies to interferon-γ in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 38 e10 14

15. HoflichC

SabatR

RosseauS

TemmesfeldB

SlevogtH

2004 Naturally occurring anti-IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 103 673 675

16. KampmannB

HemingwayC

StephensA

DavidsonR

GoodsallA

2005 Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ. J Clin Invest 115 2480 2488

17. PatelSY

DingL

BrownMR

LantzL

GayT

2005 Anti-IFN-γ autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 175 4769 4776

18. TanakaY

HoriT

ItoK

FujitaT

IshikawaT

2007 Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-γ. Intern Med 46 1005 1009

19. KoyaT

TsubataC

KagamuH

KoyamaK

HayashiM

2009 Anti-interferon-γ autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother 15 118 122

20. BaerleckenN

JacobsR

StollM

SchmidtRE

WitteT

2009 Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-γ autoantibody. Clin Infect Dis 49 e76 78

21. CasanovaJL

AbelL

2002 Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20 581 620

22. PuelA

PicardC

LorrotM

PonsC

ChrabiehM

2008 Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol 180 647 654

23. van der PollT

KeoghCV

GuiraoX

BuurmanWA

KopfM

1997 Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176 439 444

24. van EnckevortFH

SweepCG

SpanPN

NeteaMG

HermusAR

2001 Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur Cytokine Netw 12 581 586

25. ColeN

BaoS

StapletonF

ThakurA

HusbandAJ

2003 Pseudomonas aeruginosa keratitis in IL-6-deficient mice. Int Arch Allergy Immunol 130 165 172

26. DiaoH

KohanawaM

2005 Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun 73 3745 3748

27. KitamuraT

TanakaN

WatanabeJ

Uchida, KanegasakiS

1999 Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 190 875 880

28. UchidaK

NakataK

SuzukiT

LuisettiM

WatanabeM

2009 Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 113 2547 2556

29. UchidaK

BeckDC

YamamotoT

BerclazPY

AbeS

2007 GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 356 567 579

30. UchidaK

NakataK

TrapnellBC

TerakawaT

HamanoE

2004 High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 103 1089 1098

31. NakataK

KanazawaH

WatanabeM

2006 Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung? Respirology 11 Suppl S65 69

32. SakagamiT

UchidaK

SuzukiT

CareyBC

WoodRE

2009 Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med 361 2679 2681

33. SuzukiT

SakagamiT

RubinBK

NogeeLM

WoodRE

2008 Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med 205 2703 2710

34. ContiHR

ShenF

NayyarN

StocumE

SunJN

2009 Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206 299 311

35. LinL

IbrahimAS

XuX

FarberJM

AvanesianV

2009 Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5 e1000703 doi:10.1371/journal.ppat.1000703

36. KisandK

Boe WolffAS

PodkrajsekKT

TserelL

LinkM

2010 Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 207 299 308

37. PuelA

DoffingerR

NatividadA

ChrabiehM

Barcenas-MoralesG

2010 Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207 291 297

38. de BeaucoudreyL

PuelA

Filipe-SantosO

CobatA

GhandilP

2008 Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 205 1543 1550

39. MeagerA

WadhwaM

DilgerP

BirdC

ThorpeR

2003 Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-α, interferon-ω and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol 132 128 136

40. ZhangW

LiuJL

MeagerA

Newsom-DavisJ

WillcoxN

2003 Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-γ responses of healthy CD4+ T cells. J Neuroimmunol 139 102 108

41. van de VosseE

van DisselJT

OttenhoffTH

2009 Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 9 688 698

42. FerwerdaB

FerwerdaG

PlantingaTS

WillmentJA

van SprielAB

2009 Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361 1760 1767

43. GlockerEO

HennigsA

NabaviM

SchafferAA

WoellnerC

2009 A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361 1727 1735

44. CawsM

ThwaitesG

DunstanS

HawnTR

LanNT

2008 The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 4 e1000034 doi:10.1371/journal.ppat.1000034

45. MeagerA

VisvalingamK

PetersonP

MollK

MurumagiA

2006 Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3 e289 doi:10.1371/journal.pmed.0030289

46. EdwardsJC

CambridgeG

2006 B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6 394 403

47. TedderTF

2009 CD19: a promising B cell target for rheumatoid arthritis. Nat Rev Rheumatol 5 572 577

48. DornerT

RadbruchA

BurmesterGR

2009 B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol 5 433 441

49. KorhonenR

MoilanenE

2009 Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis. Basic Clin Pharmacol Toxicol 106 13 21

50. McDonaldV

LeandroM

2009 Rituximab in non-haematological disorders of adults and its mode of action. Br J Haematol 146 233 246

51. KazatchkineMD

KaveriSV

2001 Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345 747 755

52. Tha-InT

BayryJ

MetselaarHJ

KaveriSV

KwekkeboomJ

2008 Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 29 608 615

53. BayryJ

Lacroix-DesmazesS

KazatchkineMD

KaveriSV

2004 Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci 25 306 310

54. AhmedAR

SpigelmanZ

CavaciniLA

PosnerMR

2006 Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med 355 1772 1779

55. VoAA

LukovskyM

ToyodaM

WangJ

ReinsmoenNL

2008 Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359 242 251

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa